Teladoc Health Reports Third-Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Teladoc (TDOC) Tops Q3 EPS by 12c, Offers Q3 Guidance
October 26, 2022 4:11 PM EDTTeladoc (NYSE: TDOC) reported Q3 EPS of ($0.45), $0.12 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $611.4 million versus the consensus estimate of $608.76 million.
GUIDANCE:
Teladoc sees Q4 2022 EPS of ($0.40)-($0.10), versus the consensus of ($0.26). Teladoc sees Q4... More
